PureTech Appoints Robert Lyne as Chief Executive Officer

Boston, MA, December 18, 2025 (Business Wire) -- PureTech Health plc announced that its Board of Directors has appointed Robert Lyne as Chief Executive Officer (CEO) and a member of the Board, effective immediately. Lyne had served as interim CEO since July 2025 and joined PureTech in January 2024 as Chief Portfolio Officer. His leadership priorities include advancing financing for emerging entities such as Celea Therapeutics following recent regulatory progress, while sharpening strategic focus and operational efficiency.

Read full article here.